Day: February 24, 2026

Planning for phase 1/2 clinical trial initiation in Australia utilizing CYWC628 to treat diabetic foot ulcers in the first half of 2026 Improved balance sheet through multiple direct offerings; completed payments of outstanding debt HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced full year 2025 financial results and provided a corporate update. Recent Highlights Secured both public and private Human Research Ethics Committee (HREC) approvals in Australia for a Phase 1/2 clinical trial evaluating CYWC628 for the treatment of refractory diabetic foot ulcers...

Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating:• Robust ORR of 72.2% (vs 43.2% with combined SoC of FOLFOX/bev and FOLFIRI/bev)• Significant improvement in PFS over combined SoC (HR: 0.37, p

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings per diluted common share outstanding (“EPS”) for the year ended December 31, 2025 were $8.75 and $9.76, respectively. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA...

         Net Income per Diluted Share of $0.99 for the Fourth Quarter and $10.84 for the Full Year of 2025 Core FFO per Share of $1.40 for the Fourth Quarter and $6.68 for the Full Year of 2025         North America Same Property NOI increased by 7.9% for the Fourth Quarter and 5.7% for the Full Year of 2025         Acquired 14 MH and RV Communities for $457.0 million and Distributed Over $1.5 Billion of Capital to Shareholders, Inclusive of Cash Distributions and Share Repurchases in 2025         Establishing Guidance for 2026, Expecting: Core FFO per Share of $6.83 to $7.03 North American Same Property NOI Growth of 4.5% at the Midpoint; and UK Same Property NOI Growth of 2.2% at the Midpoint         Southfield, MI, Feb. 24, 2026 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE: SUI) (the “Company”...

– Initial 2026 AFFO Guidance of $1.39 to $1.41 per diluted share –– Initial 2026 Acquisition Volume Guidance of $115 Million to $125 Million –– Subsequently Expanded Aggregate Unsecured Credit Facilities by $115 Million to $555 Million –– Subsequent $44.2 Million of Equity Sales via ATM Program – CEDARHURST, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,200 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, today announced results for the quarter and year ended December 31, 2025. Highlights for the Quarter Ended December 31, 2025Acquired 65 USPS properties for approximately...

BENBROOK, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the fourth fiscal quarter and full year 2025. Highlights from 2025:Revenues were $76.3 million, up 2.6% from 2024 Generated operating loss of $1.0 million versus income of $0.6 million in 2024 Net income of $9.1 million versus $0.8 million in 2024 Gross margins of 57.0%, up from 56.2% in 2024 Operating expenses $44.5 million, up 8.1% from 2024 Adjusted EBITDA* (from operations) of $0.6 million Ended year with $16.1 million of cash and cash equivalentsTandy Leather Factory’s fourth quarter sales were $22.2 million in 2025, up from $20.5 million in 2024. Fourth quarter 2025 gross profit was $12.1 million, up from $10.8 million in 2024. As of December 31, 2025, the Company held $16.1...

BELLINGHAM, Wash., Feb. 24, 2026 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI) (the “Company,” “eXp” or “we”), the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a defining year for eXp Realty, validating our belief that transparency and agent empowerment are the only sustainable paths forward,” said Leo Pareja, CEO of eXp Realty. “Our results reflect a year of relentless execution where the industry took notice of our momentum. We aggressively strengthened our value stack, from innovations in our AI-enabled platform to the rollout of the co-sponsor program, and key leadership appointments that position us for scale. We expect 2026 to be a pivotal year as our prior investments...

– Gross Premiums Written in the Fourth Quarter Grew 56.7% Year-over-Year to $618.5 Million – – Fourth Quarter Net Income More than Doubled Year-over-Year to $170.4 Million; $1.23 Diluted Earnings Per Share – – Combined Ratio Improved to 38.0% – TAMPA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) — Slide Insurance Holdings, Inc. (“Slide” or the “Company”) (Nasdaq: SLDE) today reported results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 HighlightsGross premiums written grew 56.7% to $618.5 million, compared to $394.6 million in the prior-year period. Total policies in force at the end of the period are 493,532, the average premium per residential policy is $3,670 and the average premium per commercial residential policy is $143,213 Total revenue increased 45.5%...